Anti-PD-1 antibodies, a novel treatment option for advanced chemoresistant pulmonary lymphoepithelioma carcinoma

Overview of attention for article published in Frontiers in immunology, December 2022

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 50,414 followers.

Anti-PD-1 antibodies, a novel treatment option for advanced chemoresistant pulmonary lymphoepithelioma carcinoma https://t.co/FhxIPiXPRN https://t.co/d273Jr0wp6

09 Dec 2022

Reply Repost Favourite

New Research: Anti-PD-1 antibodies, a novel treatment option for advanced chemoresistant pulmonary lymphoepithelioma carcinoma: Background Pulmonary lymphoepithelioma-like carcinoma (LELC) exhibits a unique immune microenvironment, including… https://t.co

06 Dec 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.